Feds are ‘eyeing triggers’ to be able to deploy their vaccine, according to news brief.
The Center for Infectious Disease Research and Policy at the University of Minnesota issued a news brief Wednesday confirming that the US Department of Health and Human Services (HHS) is going forward with production of 4.8 million H5N1 avian influenza (bird flu) vaccinations.
Clinical trials for the bird flu vaccine have been underway since at least 2005 when medical test subjects were injected with the experimental vaccination.
“Dawn O’Connell, JD, said health officials have identified a manufacturing line at one of its manufacturing partners for fill-and-finish steps, without disrupting production of seasonal flu vaccine. Currently, the vaccine is in bulk form and will be produced in multidose vials,” the news brief said. “She said it takes a couple months to fill and finish the vaccine doses, which would save time in case a vaccine is needed. Federal health officials have said one of two H5N1 candidate vaccine viruses is well matched to the circulating strain.”
Federal agencies are currently in discussions regarding what events will trigger them injecting the vaccines into Americans, while mRNA manufacturers Pfizer and Moderna will soon announce their involvement in the scheme.
“O’Connell added that active discussions are under way across federal agencies about what the key triggers would be for deploying H5N1 vaccine doses. She also said discussions are still under way with mRNA vaccine makers Pfizer and Moderna, with an announcement expected soon on how the companies might be involved in vaccine development,” the news brief said.
Dr. Peter McCullough discussed one of the more alarming new bird flu vaccines on The Santilli Report.
“…and right behind it is self-replicating messenger RNA bird flu vaccines for humans, we’re taking messenger RNA, Pete [Santilli], on steroids,” McCullough said.
Dr. McCullough: Military Contractor BARDA Has Already Purchased The Bird Flu Vaxxine. “It’s ready to go” pic.twitter.com/KNu54cRFLI
— Jessica Rojas ??? (@catsscareme2021) May 23, 2024
Some key triggers which may lead to the injection of the public were already proposed by a federal agency official.
“Nirav Shah, MD, JD, principal deputy director at the Centers for Disease Control and Prevention (CDC) said potential trigger factors might include a change in transmission propensity, such as human-to-human in addition to animal-to-human spread, and any sign of increased illness severity,” the news brief said. “He also said a change in the complexion of the cases might be a trigger, such as H5N1 infections cropping up in people who have no epidemiologic links to affected dairy farms. “And we’re always looking for mutations,” Shah said. “We’re in rich discussions across federal agencies.””
The vaccination plan comes after The Food and Drug Administration (FDA) Commissioner Dr. Robert Califf told a Senate Appropriations subcommittee that his agency is preparing for the virus to make the jump to humans and other government alerts that the bird flu has been found in cows milk.
Bird flu has previously been reported to be weaponized via gain-of-function research.
Keep a watch for clade (original source) 2.3.4.4b manipulated by mankind gain-of-function highly pathogenic avian influenza. Can’t hide a lab leak this time–we have it nailed from the outside. Traveling via mallard ducks all over the the world. Likely origin, USDA Poultry… https://t.co/JkXkanyR7t pic.twitter.com/wrDAsp2er8
— Peter A. McCullough, MD, MPH® (@P_McCulloughMD) May 22, 2024
Globalists May Release New Bird Flu Strain In Attempt To Stop Trump, Warns Edward Dowd
